<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04794400</url>
  </required_header>
  <id_info>
    <org_study_id>2020-07078</org_study_id>
    <nct_id>NCT04794400</nct_id>
  </id_info>
  <brief_title>The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.</brief_title>
  <official_title>The Application of a Mask in Patients With Severe Covid-19 Already Treated With High-flow Nasal Cannula.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with severe hypoxemic respiratory failure due to Covid-19 are often treated with&#xD;
      oxygen delivered through a high-flow nasal cannula (HFNC). This is according to guidelines.&#xD;
      We have made the clinical observation that oxygenation sometimes improves when a mask (e.g.&#xD;
      oxygen mask or inhalation mask) is applied on top of the HFNC. This has quickly become a&#xD;
      clinical routine at intermediary care units at our hospital, where patients with HFNC are&#xD;
      offered to test the intervention (mask + HFNC) as part of clinical routine.&#xD;
&#xD;
      This study aims to evaluate this new routine in a standardised way.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with severe covid-19, treated with HFNC, will be approached for consent. If&#xD;
      inclusion critera and no exclusion criteria are fulfilled, baseline measurements will be&#xD;
      taken without mask, including arterial blood gas analysis (ABG)&#xD;
&#xD;
      Then a simple oxygen mask will be applied covering nose and mouth, without providing&#xD;
      supplemental oxygen. After 30 minutes with mask + HFNC, new measurements will be taken,&#xD;
      including ABG.&#xD;
&#xD;
      After 30 minutes, the mask is removed and when steady state occurs, new measurements will be&#xD;
      taken, without ABG. Then, the patients could continue using the mask as part of clinical&#xD;
      routine&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 4, 2021</start_date>
  <completion_date type="Actual">March 31, 2021</completion_date>
  <primary_completion_date type="Actual">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygenation</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in SaO2 in % from ABG with mask vs without mask</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carbon dioxide</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in PaCO2 in KPa from ABG with mask vs without mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>60 minutes</time_frame>
    <description>Change in peripherally measured oxygen saturation before, with and after mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>30 minutes</time_frame>
    <description>Change in respiratory rate (breaths/min) with mask vs without mask</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An additional oxygen mask was applied for 30 minutes, in patients with ongoing HFNC treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>oxygen mask</intervention_name>
    <description>All patients fulfilling inclusion criteria would be offered to test the intervention as part of their care. The intervention consisted only of a standardised way to evaluate this new clinical routine.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Verified Covid19 infection&#xD;
&#xD;
          -  treatment with HFNC&#xD;
&#xD;
          -  Estimated P/F ratio of ≤ 13 KPa&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  language barrier&#xD;
&#xD;
          -  unable to provide consent&#xD;
&#xD;
          -  risk of deterioration due to study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustav Torisson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skåne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skåne University Hospital</name>
      <address>
        <city>Malmö</city>
        <state>Skåne</state>
        <zip>20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>June 5, 2021</last_update_submitted>
  <last_update_submitted_qc>June 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Region Skane</investigator_affiliation>
    <investigator_full_name>Gustav Torisson</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Critical care</keyword>
  <keyword>Non-invasive ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

